Literature DB >> 27644894

Extracellular Vesicles: Immunomodulatory messengers in the context of tissue repair/regeneration.

Andreia M Silva1, José H Teixeira2, Maria Ines Almeida3, Raquel M Gonçalves4, Mário A Barbosa5, Susana G Santos6.   

Abstract

Inflammation is a complex and highly regulated biological process, crucial for a variety of functions in the human body, from host response against infectious agents to initiation of repair/regeneration of injured tissues. In the context of tissue repair, the action of different immune cell populations and their interplay with tissue specific cells, including stem cells, is still being uncovered. Extracellular Vesicles (EV) are small membrane vesicles secreted by cells in a controlled manner, which can act locally and systemically. The ability of EV to influence tissue repair and regeneration has been proposed as a physiologically intelligent and targeted strategy of cell communication. Herein, the role of EV in tissue repair is reviewed, summarising first their contribution to the regulation of immune cell function, and discussing the implications for the resolution of inflammation during repair. Next, the impact of EV on cell proliferation and differentiation, and on extracellular matrix remodelling, key aspects of the subsequent phases of tissue repair, is addressed. Finally, EV-based therapies are discussed, focusing on the application of naturally produced EV, and the use of EV as delivery vehicles.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug delivery; Exosomes; Extracellular Vesicles; Immune cells; Inflammation; Mesenchymal stromal cells

Mesh:

Year:  2016        PMID: 27644894     DOI: 10.1016/j.ejps.2016.09.017

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  32 in total

1.  Extracellular vesicles: small bricks for tissue repair/regeneration.

Authors:  Simona Taverna; Marzia Pucci; Riccardo Alessandro
Journal:  Ann Transl Med       Date:  2017-02

2.  Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science.

Authors:  Lucian Beer; Michael Mildner; Hendrik Jan Ankersmit
Journal:  Ann Transl Med       Date:  2017-04

3.  Nexus between extracellular vesicles, immunomodulation and tissue remodeling: for good or for bad?

Authors:  Farah Fatima; Muhammad Nawaz
Journal:  Ann Transl Med       Date:  2017-03

4.  Multiplexed Isobaric Tag-Based Profiling of Seven Murine Tissues Following In Vivo Nicotine Treatment Using a Minimalistic Proteomics Strategy.

Authors:  Joao A Paulo; Mark P Jedrychowski; Edward T Chouchani; Lawrence Kazak; Steven P Gygi
Journal:  Proteomics       Date:  2018-05-02       Impact factor: 3.984

Review 5.  Bone physiology as inspiration for tissue regenerative therapies.

Authors:  Diana Lopes; Cláudia Martins-Cruz; Mariana B Oliveira; João F Mano
Journal:  Biomaterials       Date:  2018-09-17       Impact factor: 12.479

6.  TBC1D3 regulates the payload and biological activity of extracellular vesicles that mediate tissue repair.

Authors:  Shu Qin; Robert A Dorschner; Irene Masini; Ophelia Lavoie-Gagne; Philip D Stahl; Todd W Costantini; Andrew Baird; Brian P Eliceiri
Journal:  FASEB J       Date:  2019-02-04       Impact factor: 5.834

7.  Extracellular vesicle therapeutics from plasma and adipose tissue.

Authors:  Dalila Iannotta; Man Yang; Christian Celia; Luisa Di Marzio; Joy Wolfram
Journal:  Nano Today       Date:  2021-04-27       Impact factor: 18.962

Review 8.  Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis.

Authors:  Joseph Withrow; Cameron Murphy; Yutao Liu; Monte Hunter; Sadanand Fulzele; Mark W Hamrick
Journal:  Arthritis Res Ther       Date:  2016-12-01       Impact factor: 5.156

Review 9.  Extracellular Vesicles, Tunneling Nanotubes, and Cellular Interplay: Synergies and Missing Links.

Authors:  Muhammad Nawaz; Farah Fatima
Journal:  Front Mol Biosci       Date:  2017-07-18

10.  Exosomal miR-218-5p/miR-363-3p from Endothelial Progenitor Cells Ameliorate Myocardial Infarction by Targeting the p53/JMY Signaling Pathway.

Authors:  Xiao Ke; Rongfeng Yang; Fang Wu; Xing Wang; Jiawen Liang; Xun Hu; Chengheng Hu
Journal:  Oxid Med Cell Longev       Date:  2021-07-16       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.